Circulating Tumor DNA Is Prognostic of Patient Outcome and Enables Therapy Monitoring in Metastatic Uveal Melanoma
Year: 2025
Type: article
Language: en
Topic: Ocular Oncology and Treatments
Authors and affiliations:
raw_author_name: Egle Ramelyte
raw_affiliation_strings: 1Department of Dermatology, University Hospital Zurich, and Faculty of Medicine, University of Zurich, Zurich, Switzerland
University Hospital of Zurich 1 Zurich
raw_author_name: Julian Kött
raw_affiliation_strings: 2Department of Dermatology and Venereology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
3Fleur Hiege Center for Skin Cancer Research, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
University Medical Center Hamburg-Eppendorf 2 Hamburg
raw_author_name: Aleigha R. Lawless
raw_affiliation_strings: 4Mass General Cancer Center, Harvard Medical School, Boston, Massachusetts
Massachusetts General Hospital 3 Boston, MA
raw_author_name: Amélie Ciernik
raw_affiliation_strings: 1Department of Dermatology, University Hospital Zurich, and Faculty of Medicine, University of Zurich, Zurich, Switzerland
University Hospital of Zurich 1 Zurich
raw_author_name: Isabel Heidrich
raw_affiliation_strings: 2Department of Dermatology and Venereology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
3Fleur Hiege Center for Skin Cancer Research, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
5Institute of Tumor Biology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
University Medical Center Hamburg-Eppendorf 2 Hamburg
raw_author_name: Caroline Zellweger
raw_affiliation_strings: 6Institute for Diagnostic and Interventional Radiology, University Hospital Zurich, Zurich, Switzerland
University Hospital of Zurich 1 Zurich
raw_author_name: Kamaneh Montazeri
raw_affiliation_strings: 3Fleur Hiege Center for Skin Cancer Research, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
Massachusetts General Hospital Cancer Center Boston, MA United States
raw_author_name: Joanna Mangana
raw_affiliation_strings: 1Department of Dermatology, University Hospital Zurich, and Faculty of Medicine, University of Zurich, Zurich, Switzerland
University Hospital of Zurich 5 Zuerich
raw_author_name: Daniel J. Smit
raw_affiliation_strings: 3Fleur Hiege Center for Skin Cancer Research, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
5Institute of Tumor Biology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
University Medical Center Hamburg-Eppendorf 2 Hamburg
raw_author_name: Sandra N. Freiberger
raw_affiliation_strings: 7Oncobit AG, Schlieren, Switzerland
Oncobit AG Schlieren Switzerland
raw_author_name: Stephany Orjuela
raw_affiliation_strings: 7Oncobit AG, Schlieren, Switzerland
Oncobit AG Schlieren, Zurich Switzerland
raw_author_name: Reinhard Dummer
raw_affiliation_strings: 1Department of Dermatology, University Hospital Zurich, and Faculty of Medicine, University of Zurich, Zurich, Switzerland
University Hospital of Zurich 1 Zurich
raw_author_name: Ryan J. Sullivan
raw_affiliation_strings: 4Mass General Cancer Center, Harvard Medical School, Boston, Massachusetts
Massachusetts General Hospital Cancer Center Boston, MA United States
raw_author_name: Mitchell P. Levesque
raw_affiliation_strings: 1Department of Dermatology, University Hospital Zurich, and Faculty of Medicine, University of Zurich, Zurich, Switzerland
University of Zurich 8 Zurich
raw_author_name: Christoffer Gebhardt
raw_affiliation_strings: 2Department of Dermatology and Venereology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
3Fleur Hiege Center for Skin Cancer Research, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
University Medical Center Hamburg-Eppendorf 2 Hamburg